Abstract
Purpose
Materials and Methods
Results
Notes
Ethical Statement
This study was conducted in accordance with the Declaration of Helsinki and had been authorized by the Ethics Committee of Peking University Cancer Hospital (Reference No. 2018KT97) before beginning the study. Each patient in this study provided signed informed consent.
Author Contributions
Conceived and designed the analysis: Ji J.
Collected the data: Ji X, Jin C, Ji K, Zhang J, Wu X, Jia Z, Bu Z.
Contributed data or analysis tools: Ji X, Jin C, Ji K, Zhang J, Wu X, Jia Z, Bu Z.
Performed the analysis: Ji X, Jin C, Ji K, Zhang J, Wu X, Jia Z, Bu Z.
Wrote the paper: Ji X, Jin C, Ji K.
ACKNOWLEDGMENTS
References
Table 1.
Clinicopathological characteristic | EG (n=39) | DT (n=25) | p-value |
---|---|---|---|
Age (yr) | 62.1±9.1 | 64.5±8.9 | 0.314 |
Sex | |||
Male | 31 (79.5) | 24 (96.0) | 0.137 |
Female | 8 (20.5) | 1 (4.0) | |
BMI (kg/m2) | 24.5±3.7 | 24.5±2.6 | 0.983 |
Tumor location | |||
AEG | 22 (56.3) | 15 (60.0) | 0.860 |
Upper third of the stomach | 17 (43.6) | 10 (40.0) | |
Proximal margin (cm) | 2.0 (1.5-2.0) | 2.0 (1.2-3.0) | 0.408 |
Distal margin (cm) | 5.0 (2.5-6.0) | 5.0 (3.0-7.5) | 0.293 |
Differentiation | |||
Well | 6 (15.4) | 5 (20.0) | 0.887 |
Moderate | 17 (43.6) | 10 (40.0) | |
Poor | 16 (41.0) | 10 (40.0) | |
Lauren classification | |||
Intestinal | 24 (61.5) | 14 (56.0) | 0.788 |
Diffuse | 7 (18.0) | 4 (16.0) | |
Mixed | 8 (20.5) | 7 (28.0) | |
Tumor size (cm) | 3.0 (2.0-4.0) | 1.5 (1.2-3.0) | 0.010a) |
pT categoryb) | |||
T1a | 8 (20.5) | 5 (20.0) | 0.033a) |
T1b | 9 (23.1) | 13 (52.0) | |
T2 | 8 (20.5) | 6 (24.0) | |
T3 | 10 (25.6) | 1 (4.0) | |
T4a | 4 (10.3) | 0 | |
T4b | 0 | 0 | |
pN categoryb) | |||
N0 | 24 (61.5) | 23 (92.0) | 0.034a) |
N1 | 5 (12.8) | 2 (8.0) | |
N2 | 8 (20.5) | 0 | |
N3a | 2 (5.2) | 0 | |
N3b | 0 | 0 | |
pTNM categoryb) | |||
IA | 16 (41.0) | 17 (68.0) | 0.031a) |
IB | 5 (12.8) | 6 (24.0) | |
IIA | 4 (10.3) | 2 (8.0) | |
IIB | 8 (20.5) | 0 | |
IIIA | 4 (10.3) | 0 | |
IIIB | 2 (5.1) | 0 | |
IIIC | 0 | 0 | |
No. of harvested LNs | 22.5 (17.0-31.0) | 19.0 (16.3-23.0) | 0.055 |
Degree of LND | |||
D1 | 8 (20.5) | 11 (44.0) | 0.045a) |
D1+ | 31 (79.5) | 14 (56.0) | |
LVI | |||
No | 23 (59.0) | 20 (80.0) | 0.080 |
Yes | 16 (41.0) | 5 (20.0) | |
PNI | |||
No | 24 (61.5) | 22 (88.0) | 0.044a) |
Yes | 15 (38.5) | 3 (12.0) | |
Adjuvant chemotherapy | |||
No | 16 (41.0) | 17 (68.0) | 0.035a) |
Yes | 23 (59.0) | 8 (32.0) |
Values are presented as mean±SD, number (%), or median (IQR). AEG, adenocarcinoma of the esophagogastric junction; AJCC, American Joint Committee on Cancer; BMI, body mass index; DT, double tract reconstruction; EG, esophagogastrostomy; IQR, interquartile range; LN, lymph node; LND, lymph node dissection; LVI, lymphovascular invasion; PNI, perineural invasion; SD, standard deviation; UICC, Union for International Cancer Control.
Table 2.
Perioperative parameter | EG (n=39) | DT (n=25) | p-value |
---|---|---|---|
Postoperative hospital stay (day) | 11 (10-14) | 13 (11-18) | 0.220 |
Operation duration (min) | 195 (170-240) | 240 (210-270) | 0.001a) |
Blood loss volume (mL) | 100 (50-100) | 50 (50-100) | 0.189 |
Postoperative complicationb) | |||
No | 32 (82.1) | 21 (84.0) | > 0.99 |
Yes | 7 (17.9) | 4 (16.0) | |
Clavien-Dindo classification | |||
Grade I | |||
Pulmonary infection | 0 | 1 (4.0) | |
Gastrointestinal dysfunction | 2 (5.1) | 0 (5.1) | |
Grade II | |||
Anastomotic leakage | 3 (7.7) | 2 (8.0) | |
Peritoneal effusion or abscess | 3 (7.7) | 2 (8.0) | |
Pulmonary infection | 0 | 1 (4.0) | |
Anemia | 1 (2.6) | 0 | |
Grade III | |||
Anastomotic leakage | 1 (2.6) | 0 | |
30-Day reoperation rate | 0 | 0 | > 0.99 |
30-Day mortality rate | 0 | 0 | > 0.99 |
Reflux esophagitis | |||
No | 27 (69.2) | 23 (92.0) | 0.032a) |
Yes | 12 (30.8) | 2 (8.0) | |
Los Angeles classification | |||
A | 9 (23.1) | 2 (8.0) | |
B | 3 (7.7) | 0 |
Table 3.
Univariate analysis |
Multivariate analysis |
|||||
---|---|---|---|---|---|---|
Variable | p-value | Variable | p-value | Variable | OR (95% CI) | p-value |
Age | 0.696 | pTNM stage | 0.405 | Reconstruction method | ||
Sex | 0.644 | No. of harvested LNs | 0.179 | EG | 1 | 0.004a) |
BMI | 0.408 | Degree of LND | 0.526 | DT | 0.078 (0.009-0.674) | |
Tumor location | > 0.99 | LVI | > 0.99 | |||
Proximal margin | 0.568 | PNI | 0.085 | |||
Distal margin | 0.418 | Adjuvant chemotherapy | 0.232 | |||
Differentiation | > 0.99 | Operation duration | 0.128 | |||
Lauren classification | 0.143 | Blood loss volume | 0.113 | |||
Tumor size | 0.689 | Postoperative hospital stay | 0.318 | |||
pT category | 0.153 | Postoperative complication | > 0.99 | |||
pN category | 0.518 | Reconstruction method | 0.032a) |
Table 4.
Scale | EG | DT | p-value |
---|---|---|---|
EORTC QLQ-C30 | |||
Global health status | 50.0 (33.3-50.0) | 83.3 (66.7-83.3) | < 0.001a) |
Functional scales | |||
Physical functioning | 80.0 (66.7-86.7) | 80 (66.7-86.7) | 0.600 |
Role functioning | 66.7 (66.7-66.7) | 66.7 (66.7-83.3) | 0.108 |
Emotional functioning | 50.0 (41.7-66.7) | 66.7 (66.7-79.2) | < 0.001a) |
Cognitive functioning | 100.0 (66.7-100.0) | 100.0 (75.0-100.0) | 0.142 |
Social functioning | 66.7 (66.7-66.7) | 66.7 (66.7-83.3) | 0.073 |
Symptom scales | |||
Fatigue | 33.3 (33.3-33.3) | 33.3 (0.0-33.3) | 0.473 |
Nausea and vomiting | 50.0 (50.0-83.3) | 16.7 (16.7-16.7) | < 0.001a) |
Pain | 16.7 (16.7-33.3) | 16.7 (0.0-33.3) | 0.039a) |
Dyspnea | 0.0 (0.0-33.3) | 0.0 (0.0-0.0) | 0.072 |
Insomnia | 33.3 (0.0-33.3) | 0.0 (0.0-0.0) | 0.003a) |
Appetite loss | 33.3 (33.3-33.3) | 0.0 (0.0-33.3) | < 0.001a) |
Constipation | 0.0 (0.0-33.3) | 0.0 (0.0-0.0) | 0.082 |
Diarrhea | 0.0 (0.0-33.3) | 0.0 (0.0-0.0) | 0.129 |
Financial difficulties | 33.3 (0.0-33.3) | 33.3 (0.0-33.3) | 0.638 |
EORTC QLQ-STO22 | |||
Dysphagia | 22.2 (11.1-33.3) | 11.1 (11.1-22.2) | 0.030a) |
Pain | 33.3 (16.7-41.7) | 25.0 (12.5-25.0) | 0.008a) |
Reflux | 88.9 (66.7-100.0) | 33.3 (0.0-44.4) | < 0.001a) |
Eating | 41.7 (33.3-66.7) | 25.0 (20.8-33.3) | < 0.001a) |
Anxiety | 77.8 (66.7-100.0) | 55.6 (44.4-66.7) | < 0.001a) |
Dry mouth | 33.3 (33.3-66.7) | 33.3 (0.0-33.3) | 0.007a) |
Taste | 66.7 (33.3-66.7) | 33.3 (0.0-33.3) | 0.001a) |
Body image | 66.7 (66.7-100.0) | 66.7 (66.7-100.0) | 0.807 |
Hair loss | 0.0 (0.0-0.0) | 0.0 (0.0-33.3) | 0.494 |
Table 5.
Simple analysis |
Multiple analysis |
||||
---|---|---|---|---|---|
Variable | p-value | Variable | p-value | Variable | p-value |
Age | 0.339 | Number of harvested LNs | 0.130 | Reconstruction method | < 0.001a) |
Sex | 0.057 | Degree of LND | 0.180 | Postoperative complication | < 0.001a) |
BMI | 0.828 | LVI | 0.284 | Reflux esophagitis | 0.003a) |
Tumor location | 0.601 | PNI | 0.022a) | Operation duration | 0.001a) |
Proximal margin | 0.436 | Adjuvant chemotherapy | 0.052 | ||
Distal margin | 0.128 | Operation duration | 0.008a) | ||
Differentiation | 0.703 | Blood loss volume | 0.219 | ||
Lauren classification | 0.416 | Postoperative hospital stay | 0.215 | ||
Tumor size | 0.085 | Postoperative complication | 0.060 | ||
pT category | 0.035a) | Reflux esophagitis | 0.001a) | ||
pN category | 0.016a) | Reconstruction method | 0.001a) | ||
pTNM category | 0.015a) |
Table 6.
Linear regression equation | Adjusted R-squared | F-value | p-value |
---|---|---|---|
0.791 | 22.961 | < 0.001a) | |
GHS score=23.8×RM+0.1×OD−14.3×PC−9.6×RE+44.2 | |||
RM: double tract reconstruction=1, esophagogastrostomy=0 | |||
OD: operation duration, expressed in minutes | |||
PC: without complication=0, with complication=1 | |||
RE: without reflux esophagitis=0, with reflux esophagitis=1 |